Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.

by | May 6, 2026 | Clinical Trials | 0 comments

​ Conditions: Glioblastoma

Interventions: Procedure: Fluorescence-guided resection (FGR)

Sponsors: University Hospital, Lille; Lille University

Not yet recruiting Conditions: Glioblastoma
Interventions: Procedure: Fluorescence-guided resection (FGR)
Sponsors: University Hospital, Lille; Lille University
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *